AestheticsPro stands out as the leading all-in-one software solution for medical aesthetics in the current market. It boasts HIPAA compliance in the cloud, features integrated point-of-sale systems, targeted advertising, and comprehensive reporting that focuses on results, all while offering electronic charting and a client portal equipped with convenient "book now" options. With AestheticsPro, you have access to every tool necessary for effectively managing your medical spa operations. Whether you are looking to streamline appointments or enhance client engagement, this software has you covered.
Learn more
Cloudflare serves as the backbone of your infrastructure, applications, teams, and software ecosystem. It offers protection and guarantees the security and reliability of your external-facing assets, including websites, APIs, applications, and various web services. Additionally, Cloudflare secures your internal resources, encompassing applications within firewalls, teams, and devices, thereby ensuring comprehensive protection. This platform also facilitates the development of applications that can scale globally. The reliability, security, and performance of your websites, APIs, and other channels are crucial for engaging effectively with customers and suppliers in an increasingly digital world. As such, Cloudflare for Infrastructure presents an all-encompassing solution for anything connected to the Internet. Your internal teams can confidently depend on applications and devices behind the firewall to enhance their workflows. As remote work continues to surge, the pressure on many organizations' VPNs and hardware solutions is becoming more pronounced, necessitating robust and reliable solutions to manage these demands.
Learn more
Hillo
We are excited to present a flexible API that integrates effortlessly with your diabetes management platform, providing customized therapeutic education along with deeper insights into fluctuations in blood glucose levels. This innovative solution allows for real-time risk assessments, which promotes a higher degree of personalization and better regulation of the system while skillfully navigating the complexities of rapid glucose changes in daily life. With the rise of telemedicine and the power of retrospective analysis, patients are equipped with comprehensive decision-support tools that enhance their management capabilities. Currently, Hillo is working on the next phases of its AI technology, which includes a therapeutic recommendation system focused on preventing both hypoglycemia and hyperglycemia, with expectations to achieve CE mark class IIB by 2020. Furthermore, a next-generation artificial pancreas is scheduled for release in 2021, set to overcome the critical limitations of current models through ultra-personalization powered by machine learning. This pioneering initiative introduces the first self-learning artificial intelligence, designed to anticipate blood glucose levels, with the goal of obtaining a CE mark as a certified medical device, thus revolutionizing diabetes management for users. Ultimately, the advancements made by Hillo have the potential to greatly improve the quality of life for those living with diabetes, empowering them to manage their condition with newfound confidence and precision.
Learn more
Omada
Digital Care Made Human™. Omada® empowers individuals to achieve their health goals through sustainable lifestyle changes. Our comprehensive digital care platform makes it easy for your workforce to access a variety of programs, providing continuous, personalized support tailored to their specific health needs. Prediabetes Prevention: An alarming statistic shows that 1 in 3 Americans are impacted by prediabetes. With Omada’s Prevention program, participants can anticipate a 30% decrease in their risk of developing Type 2 Diabetes and a 13% drop in heart disease risk. On average, individuals who complete the program lose approximately 4-5% of their body weight and are able to maintain this weight loss long-term. Diabetes Management: Alarmingly, 46% of diabetes patients struggle to achieve adequate glycemic control (A1C < 7%). Within Omada’s Diabetes program, an impressive 92% of participants report high levels of satisfaction, and those previously not meeting their health goals experienced an A1C reduction exceeding 1%. Furthermore, with Hypertension affecting 46% of the US population, our programs are specifically designed to tackle this crucial health issue effectively. With our unwavering dedication to ongoing support, individuals can confidently navigate their health journey and make informed decisions for a healthier future.
Learn more
